Bär & Karrer advised Deutsche Private Equity (DPE) on the acquisition of a majority stake in IMPAG Group, advised by Lenz & Staehelin. The transaction is subject to clearance by competition authorities and is
Tags :Bär & Karrer
Following the completion of the acquisition of Credit Suisse Group by UBS Group on 12 June 2023, and the completion of the merger between UBS and Credit Suisse (“Parent Bank Merger”) on 31 May 2024, the boards of directors
Bär & Karrer acted as legal advisor to MediaMarktSaturn on its agreement with Migros, according to which MediaMarktSaturn will take over 20 melectronics stores. The stores as well as the existing employees and apprentices will
Bär & Karrer advised investor Coatue in an oversubscribed USD 10.7 million seed financing round for DeepJudge, advised by Wenger Vieli. The round also saw participation from several angel investors such as Gokul Rajaram and
Bär & Karrer advised Banque Cantonale de Genève, e in the recent capital increase of La Foncière, a listed real estate fund. From June 3 to June 12, 2024, La Foncière successfully completed a
Homburger advised Aktiengesellschaft für die Neue Zürcher Zeitung (NZZ) on the acquisition of a 25%-stake in APG SGA (APG|SGA) from the two anchor shareholders JCDecaux, advised by Bär & Karrer, and
Following the completion of the acquisition of Credit Suisse Group by UBS Group on 12 June 2023, the boards of directors of UBS and Credit Suisse approved the merger between UBS and Credit Suisse (“Parent Bank Merger”).
Bär & Karrer advised Lalique Group on Silvio Denz’s – its majority shareholder – public tender offer for its publicly held registered shares. On 30 May 2024, Silvio Denz and Lalique entered into a transaction agreement regarding
Bär & Karrer advises funds managed by Equistone on the sale of KWC Group’s home division, a designer and manufacturer of kitchen, bathroom and washroom fittings and accessories, to Paini Rubinetterie. Bär &
Advestra advised Cactus life sciences, a global scientific communications agency that works with blue chip pharma and biotechnology companies, on nspm and eluSCIdate’
